色素-话题@MedSci

#色素#

654篇内容 | 6343人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680378, encodeId=312a16803e861, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Mol Cancer Therap：新型药物或能有效阻断90%的黑色素瘤转移, objectType=article, longId=87142, objectId=e9158e142dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9158e142dd, replyNumber=0, likeNumber=60, createdTime=2017-08-07, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9158e142dd, moduleTitle=Mol Cancer Therap：新型药物或能有效阻断90%的黑色素瘤转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9158e142dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680345, encodeId=b82e168034555, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2016黑色素瘤治疗进展汇总, objectType=article, longId=74866, objectId=9f94e4866cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f94e4866cc, replyNumber=0, likeNumber=88, createdTime=2016-11-06, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f94e4866cc, moduleTitle=2016黑色素瘤治疗进展汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f94e4866cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680355, encodeId=4187168035524, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell：黑色素瘤劫持重要免疫信号途径对抗免疫治疗, objectType=article, longId=78891, objectId=6e77e8891b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e77e8891b9, replyNumber=0, likeNumber=0, createdTime=2017-09-11, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e77e8891b9, moduleTitle=Cell：黑色素瘤劫持重要免疫信号途径对抗免疫治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e77e8891b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680362, encodeId=3742168036292, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cancer Res:添加一味神奇“佐料” 改善T细胞治疗黑色素瘤效果, objectType=article, longId=80344, objectId=c02d803449e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c02d803449e, replyNumber=0, likeNumber=0, createdTime=2017-05-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c02d803449e, moduleTitle=Cancer Res:添加一味神奇“佐料” 改善T细胞治疗黑色素瘤效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c02d803449e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680356, encodeId=3abb168035691, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】近期“黑色素瘤”相关研究汇总, objectType=article, longId=79456, objectId=45a6e94563f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45a6e94563f, replyNumber=0, likeNumber=103, createdTime=2017-04-14, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45a6e94563f, moduleTitle=【盘点】近期“黑色素瘤”相关研究汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45a6e94563f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680393, encodeId=57671680393da, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=INT J LAB HEMATOL：小细胞性贫血的鉴别诊断：小红细胞和低色素红细胞的作用, objectType=article, longId=95737, objectId=f05495e3799, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f05495e3799, replyNumber=0, likeNumber=73, createdTime=2017-10-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f05495e3799, moduleTitle=INT J LAB HEMATOL：小细胞性贫血的鉴别诊断：小红细胞和低色素红细胞的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f05495e3799)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680380, encodeId=fcf7168038079, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Dermat：分期切除与永久切除对控制头和颈部黑色素瘤的功效, objectType=article, longId=88001, objectId=5e178800176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e178800176, replyNumber=0, likeNumber=59, createdTime=2017-02-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e178800176, moduleTitle=JAMA Dermat：分期切除与永久切除对控制头和颈部黑色素瘤的功效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e178800176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680375, encodeId=32cc16803e54f, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2017 NCCN临床实践指南：黑色素瘤-证据块（2017.V1）, objectType=article, longId=83225, objectId=2a9e8322592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a9e8322592, replyNumber=0, likeNumber=31, createdTime=2017-08-16, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a9e8322592, moduleTitle=2017 NCCN临床实践指南：黑色素瘤-证据块（2017.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a9e8322592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680342, encodeId=cf8b168034274, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：黑色素瘤患者PD-1免疫疗法耐药性的机制被揭示, objectType=article, longId=72951, objectId=201ee2951b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=201ee2951b6, replyNumber=0, likeNumber=85, createdTime=2017-05-23, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=201ee2951b6, moduleTitle=NEJM：黑色素瘤患者PD-1免疫疗法耐药性的机制被揭示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=201ee2951b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680350, encodeId=a87e16803509b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：2期试验支持nivolumab+ipilimumab作为晚期黑色素瘤一线治疗（CheckMate 069）, objectType=article, longId=77259, objectId=1a9fe7259eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a9fe7259eb, replyNumber=0, likeNumber=64, createdTime=2017-03-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a9fe7259eb, moduleTitle=Lancet Oncol：2期试验支持nivolumab+ipilimumab作为晚期黑色素瘤一线治疗（CheckMate 069）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a9fe7259eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680335, encodeId=98a3168033588, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=ASCO 2016：PD-1免疫疗法Keytruda多种组合方案治疗晚期黑色素瘤表现积极数据, objectType=article, longId=70123, objectId=6af2e012384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6af2e012384, replyNumber=0, likeNumber=71, createdTime=2017-03-15, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6af2e012384, moduleTitle=ASCO 2016：PD-1免疫疗法Keytruda多种组合方案治疗晚期黑色素瘤表现积极数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6af2e012384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680360, encodeId=de851680360d0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=2015NICE指南——黑色素瘤的评估和管理（NG.14）, objectType=article, longId=79945, objectId=ad27e994541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad27e994541, replyNumber=0, likeNumber=33, createdTime=2017-01-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad27e994541, moduleTitle=2015NICE指南——黑色素瘤的评估和管理（NG.14）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad27e994541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680371, encodeId=2ec616803e1a0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Oncology：治疗黑色素瘤该选择靶向治疗还是免疫治疗？这项研究给你一个答案, objectType=article, longId=82030, objectId=9a8582030ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a8582030ac, replyNumber=0, likeNumber=79, createdTime=2016-12-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a8582030ac, moduleTitle=JAMA Oncology：治疗黑色素瘤该选择靶向治疗还是免疫治疗？这项研究给你一个答案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a8582030ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680382, encodeId=7a1a168038205, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Clin Cancer Res:抗衰老蛋白可能成为老年黑色素瘤患者的潜在治疗靶点, objectType=article, longId=90071, objectId=841d900e1db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=841d900e1db, replyNumber=0, likeNumber=58, createdTime=2017-08-28, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=841d900e1db, moduleTitle=Clin Cancer Res:抗衰老蛋白可能成为老年黑色素瘤患者的潜在治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=841d900e1db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680373, encodeId=082416803e3b2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【盘点】近期黑色素瘤重大研究进行一览, objectType=article, longId=82314, objectId=38638231422, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38638231422, replyNumber=0, likeNumber=118, createdTime=2017-07-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38638231422, moduleTitle=【盘点】近期黑色素瘤重大研究进行一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38638231422)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680348, encodeId=f62f168034821, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：治疗黑色素瘤的一线药物cobimetinib+vemurafenib, objectType=article, longId=76325, objectId=ab52e63254e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab52e63254e, replyNumber=0, likeNumber=58, createdTime=2017-02-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab52e63254e, moduleTitle=Lancet Oncol：治疗黑色素瘤的一线药物cobimetinib+vemurafenib, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab52e63254e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680349, encodeId=47c8168034979, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet、NEJM罕见“黑色素瘤”病例报道，值得一看！, objectType=article, longId=76975, objectId=af96e69750b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af96e69750b, replyNumber=0, likeNumber=62, createdTime=2016-11-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af96e69750b, moduleTitle=Lancet、NEJM罕见“黑色素瘤”病例报道，值得一看！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af96e69750b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680363, encodeId=c27b1680363d1, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Br J Cancer：靶向治疗后达到完全缓解的黑色素瘤患者，能停药吗？, objectType=article, longId=80611, objectId=eaa38061113, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaa38061113, replyNumber=0, likeNumber=77, createdTime=2017-01-04, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaa38061113, moduleTitle=Br J Cancer：靶向治疗后达到完全缓解的黑色素瘤患者，能停药吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaa38061113)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680341, encodeId=3f5a168034159, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Dermatol：黑色素瘤筛查时，肛周痣也不能放过, objectType=article, longId=72693, objectId=67a8e2693eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67a8e2693eb, replyNumber=0, likeNumber=64, createdTime=2017-06-20, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67a8e2693eb, moduleTitle=JAMA Dermatol：黑色素瘤筛查时，肛周痣也不能放过, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67a8e2693eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680333, encodeId=fc8516803335b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Cell Reports: 致癌基因BRAF突变介导了黑色素瘤的侵袭, objectType=article, longId=69564, objectId=546a69564fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546a69564fb, replyNumber=0, likeNumber=67, createdTime=2016-06-09, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546a69564fb, moduleTitle=Cell Reports: 致癌基因BRAF突变介导了黑色素瘤的侵袭, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=546a69564fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Mol Cancer Therap：新型药物或能有效阻断90%的黑色素瘤转移

2017-08-07

sunylz (审核中...)

前往app查看评论内容

#色素#

2016黑色素瘤治疗进展汇总

2016-11-06

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell：黑色素瘤劫持重要免疫信号途径对抗免疫治疗

2017-09-11

sunylz (审核中...)

前往app查看评论内容

#色素#

Cancer Res:添加一味神奇“佐料” 改善T细胞治疗黑色素瘤效果

2017-05-12

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】近期“黑色素瘤”相关研究汇总

2017-04-14

sunylz (审核中...)

前往app查看评论内容

#色素#

INT J LAB HEMATOL：小细胞性贫血的鉴别诊断：小红细胞和低色素红细胞的作用

2017-10-20

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Dermat：分期切除与永久切除对控制头和颈部黑色素瘤的功效

2017-02-01

sunylz (审核中...)

前往app查看评论内容

#色素#

2017 NCCN临床实践指南：黑色素瘤-证据块（2017.V1）

2017-08-16

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：黑色素瘤患者PD-1免疫疗法耐药性的机制被揭示

2017-05-23

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：2期试验支持nivolumab+ipilimumab作为晚期黑色素瘤一线治疗（CheckMate 069）

2017-03-31

sunylz (审核中...)

前往app查看评论内容

#色素#

ASCO 2016：PD-1免疫疗法Keytruda多种组合方案治疗晚期黑色素瘤表现积极数据

2017-03-15

sunylz (审核中...)

前往app查看评论内容

#色素#

2015NICE指南——黑色素瘤的评估和管理（NG.14）

2017-01-26

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Oncology：治疗黑色素瘤该选择靶向治疗还是免疫治疗？这项研究给你一个答案

2016-12-05

sunylz (审核中...)

前往app查看评论内容

#色素#

Clin Cancer Res:抗衰老蛋白可能成为老年黑色素瘤患者的潜在治疗靶点

2017-08-28

sunylz (审核中...)

前往app查看评论内容

#色素#

【盘点】近期黑色素瘤重大研究进行一览

2017-07-02

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：治疗黑色素瘤的一线药物cobimetinib+vemurafenib

2017-02-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet、NEJM罕见“黑色素瘤”病例报道，值得一看！

2016-11-12

sunylz (审核中...)

前往app查看评论内容

#色素#

Br J Cancer：靶向治疗后达到完全缓解的黑色素瘤患者，能停药吗？

2017-01-04

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Dermatol：黑色素瘤筛查时，肛周痣也不能放过

2017-06-20

sunylz (审核中...)

前往app查看评论内容

#色素#

Cell Reports: 致癌基因BRAF突变介导了黑色素瘤的侵袭

2016-06-09

科室
- - 订阅+
  - 更多科室
工具
服务